267 related articles for article (PubMed ID: 33031750)
1. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study.
Wei X; Yang J; Gao L; Wang L; Liao Q; Qiu Q; Luo K; Yu S; Zhou Y; Liu F; Chen Q; Zhang J; Dai B; Yang H; Zhou J; Xing W; Chen X; He M; Ren L; Guo J; Luo L; Wu P; Chen Z; van Doorn HR; Cauchemez S; Cowling BJ; Yu H
Lancet Infect Dis; 2021 Mar; 21(3):418-426. PubMed ID: 33031750
[TBL] [Abstract][Full Text] [Related]
2. The transfer of maternal antibodies and dynamics of maternal and natural infection-induced antibodies against coxsackievirus A16 in Chinese children 0-13 years of age: a longitudinal cohort study.
Zhou J; Zhou Y; Luo K; Liao Q; Zheng W; Gong H; Shi H; Zhao S; Wang K; Qiu Q; Dai B; Ren L; Wang L; Gao L; Xu M; Liu N; Lu W; Zheng N; Chen X; Chen Z; Yang J; Cauchemez S; Yu H
BMC Med; 2022 Nov; 20(1):436. PubMed ID: 36352415
[TBL] [Abstract][Full Text] [Related]
3. Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort study.
Li M; Wang W; Chen J; Zhan Z; Xu M; Liu N; Ren L; You L; Zheng W; Shi H; Zhao Z; Huang C; Chen X; Zheng N; Lu W; Zhou X; Zhou J; Liao Q; Yang J; Jit M; Salje H; Yu H
Lancet Microbe; 2023 Nov; 4(11):e893-e902. PubMed ID: 37827184
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years.
Puenpa J; Chansaenroj J; Auphimai C; Srimuan D; Thatsanathorn T; Poovorawan Y; Wanlapakorn N
Vaccine; 2020 Nov; 38(48):7638-7644. PubMed ID: 33067033
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: A longitudinal cohort study in Zhengzhou during 2017-2019.
Qiu Q; Zhou J; Cheng Y; Zhou Y; Liang L; Cui P; Xue Y; Wang L; Wang K; Wang H; Li P; Chen J; Li Y; Turtle L; Yu H
EBioMedicine; 2021 Jun; 68():103398. PubMed ID: 34049245
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of enterovirus A71 infection in prospective cohort studies of children in southern China, 2013-2018.
Yang J; Liao Q; Luo K; Liu F; Zhou Y; Zou G; Huang W; Yu S; Wei X; Zhou J; Dai B; Qiu Q; Altmeyer R; Hu H; Paireau J; Luo L; Gao L; Nikolay B; Hu S; Xing W; Wu P; van Doorn HR; Horby PW; Simmonds P; Leung GM; Cowling BJ; Cauchemez S; Yu H
Nat Commun; 2022 Nov; 13(1):7280. PubMed ID: 36435844
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam.
Kuo FL; Khanh TH; Chung WY; Hung NT; Luo ST; Chang WC; Nhan LNT; Thinh LQ; Lee MS
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008124. PubMed ID: 32126083
[TBL] [Abstract][Full Text] [Related]
9. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
Huang LM; Chiu CH; Chiu NC; Lin CY; Li MT; Kuo TY; Weng YJ; Hsieh EF; Tai IC
Vaccine; 2019 Mar; 37(13):1827-1835. PubMed ID: 30803843
[TBL] [Abstract][Full Text] [Related]
11. [Seroprevalence of the newer enterovirus types A71, A90 and B87 in healthy individuals in Shandong Province, China].
Liu XL; Wang ST; Lin XJ; Tao ZX; Wang HY; Song LZ; Zhang L; Xu AQ
Bing Du Xue Bao; 2014 Nov; 30(6):614-8. PubMed ID: 25868274
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on seroepidemiological study of enterovirus 71 and coxsackievirus A16 infection among children].
Luo L; Xing W; Liao Q; Yu H
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Feb; 49(2):184-8. PubMed ID: 26081408
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of seroepidemiology of enterovirus 71 diseases in children in Jiangsu province].
Zhou Y; Li J; Meng F; Hu Y; Jin P; Zhang X; Zhu F
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1047-51. PubMed ID: 26887297
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China.
Wang JX; Zhu SL; Wang J; Lin Y; Pei YW; Sun DP; Zhang Y; Wang XJ; Xu WB; Ding SJ
PLoS One; 2016; 11(9):e0162373. PubMed ID: 27611441
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Enterovirus A71 Seropositivity in Rural Indigenous Populations in West Malaysia.
NikNadia N; Sam IC; Khaidir N; Ngui R; Lim YA; Goh XT; Choy SH; Chan YF
PLoS One; 2016; 11(2):e0148767. PubMed ID: 26866912
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of coxsackievirus A6 and enterovirus A71 infection in humans: a systematic review and meta-analysis.
Shi Y; Chen P; Bai Y; Xu X; Liu Y
Arch Virol; 2023 Jan; 168(2):37. PubMed ID: 36609748
[TBL] [Abstract][Full Text] [Related]
17. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional seroepidemiology study of EV-D68 in China.
Sun S; Gao F; Hu Y; Bian L; Wu X; Su Y; Du R; Fu Y; Zhu F; Mao Q; Liang Z
Emerg Microbes Infect; 2018 Jun; 7(1):99. PubMed ID: 29872035
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
[TBL] [Abstract][Full Text] [Related]
20. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
